Premium
Proviral HIV‐1 dynamics and evolution in patients receiving efficient long‐term antiretroviral combination therapy
Author(s) -
Birk M,
Aleman S,
ViscoComandini U,
Sönnerborg A
Publication year - 2000
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1046/j.1468-1293.2000.00030.x
Subject(s) - viral quasispecies , peripheral blood mononuclear cell , virology , medicine , population , viral replication , viral load , immunology , polymerase chain reaction , antiretroviral therapy , virus , gene , biology , genetics , in vitro , hepatitis c virus , environmental health
Different experimental approaches have shown that, despite plasma viral loads under the threshold of detection, HIV‐1 frequently continues to replicate in patients receiving potent antiretroviral therapy. However, whether this low‐grade viral replication is sufficient for the generation of new major quasispecies has not been studied. Thus, in order to evaluate the extent of variation in the major proviral HIV‐1 population, we monitored proviral DNA sequences in such patients over a time period of up to 30 months. Methods DNA was extracted from peripheral blood mononuclear cells (PBMC) and the V3 region was amplified by nested polymerase chain reaction (PCR) and directly sequenced. Additionally, both HIV‐1 RNA and DNA levels and CD4 + T‐lymphocyte counts were monitored. Results Analysing the V3 gene sequences of 17 patients, we observed a sequence evolution in nine patients. Interestingly, the majority of these changes (77%) occurred in the first interval following the initiation of therapy and despite signs of ongoing replication the proviral DNA levels continued to decrease in all patients. Conclusions Our data suggest that, although available data report that HIV‐1 continues to replicate in patients with undetectable viraemia, the extent of viral replication in many of these patients is not sufficient to result in changes in the major viral population.